Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)
2013 ◽
Vol 31
(8)
◽
pp. 1788-1793
◽
2013 ◽
Vol 39
(4)
◽
pp. 484-492
◽
2008 ◽
Vol 26
(22)
◽
pp. 3808-3809
◽
Keyword(s):
2018 ◽
Vol 120
(2)
◽
pp. 1492-1502
◽
Keyword(s):
2012 ◽
Vol 46
(5)
◽
pp. 358-364
◽
2014 ◽
Vol 13
(6)
◽
pp. e1390
◽
Keyword(s):